VivoSim Labs (VIVS) EBITDA Margin Growth (3y) (2014 - 2026)
VivoSim Labs (VIVS) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -2,649.00 |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -973,444.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -973,444.00 |
| Mar 31, 2026 | -316,565.00 |
| Dec 31, 2025 | -801,280.00 |
| Sep 30, 2025 | -505,487.00 |
| Mar 31, 2025 | -605,678.00 |
| Dec 31, 2022 | -80,775.00 |
| Sep 30, 2022 | -380,080.00 |
| Mar 31, 2022 | 92,570.00 |
| Dec 31, 2019 | -91,963.00 |
| Sep 30, 2019 | 13,384.00 |
| Jun 30, 2019 | 888.00 |
| Mar 31, 2019 | 48,527.00 |
| Dec 31, 2018 | 235,433.00 |
| Sep 30, 2018 | 311,162.00 |
| Jun 30, 2018 | 166,434.00 |
| Mar 31, 2018 | 229,877.00 |
| Dec 31, 2017 | 380,502.00 |
| Sep 30, 2017 | 332,730.00 |
| Jun 30, 2017 | 544,444.00 |
| Sep 30, 2016 | 3.99 Mn |